REFERENCES
1. Baumgartner H, Bonhoeffer P, De Groot NMS, et al. ESC Guidelines for
the management of grown-up congenital heart disease (new version 2010).Eur Heart J . 2010;31(23):2915-2957. doi:10.1093/eurheartj/ehq249
2. Blake GE, Lakkireddy D. Atrial Fibrillation and Atrial Septal Defect.J Atr Fibrillation . 2008;1(3). doi:10.4022/jafib.v1i1.390
3. Tse HF, Pelosi F, Oral H, Knight BP, Strickberger SA, Morady F.
Effects of simultaneous atrioventricular pacing on atrial refractoriness
and atrial fibrillation inducibility: Role of atrial mechanoelectrical
feedback. J Cardiovasc Electrophysiol . 2001;12(1):43-50.
doi:10.1046/j.1540-8167.2001.00043.x
4. Gatzoulis MA, Freeman MA, Siu SC, Webb GD, Harris L. Atrial
arrhythmia after surgical closure of atrial septal defects in adults.N Engl J Med . 1999;340(11):839-846.
doi:10.1056/NEJM199903183401103
5. Wang H, Wang C, Chen J, Zhao L, Pan X. Long-term outcome of catheter
ablation for atrial tachyarrhythmias in patients with atrial septal
defect. J Interv Card Electrophysiol . 2019;54(3):217-224.
doi:10.1007/s10840-018-0505-1
6. Santangeli P, Di Biase L, Burkhardt JD, et al. Transseptal access and
atrial fibrillation ablation guided by intracardiac echocardiography in
patients with atrial septal closure devices. Heart Rhythm .
2011;8(11):1669-1675. doi:10.1016/j.hrthm.2011.06.023
7. Li X, Wissner E, Kamioka M, et al. Safety and feasibility of
transseptal puncture for atrial fibrillation ablation in patients with
atrial septal defect closure devices. Heart Rhythm .
2014;11(2):330-335. doi:10.1016/j.hrthm.2013.11.011
8. Sang CH, Dong JZ, Long DY, et al. Transseptal puncture and catheter
ablation of atrial fibrillation in patients with atrial septal occluder:
Initial experience of a single centre. Europace .
2018;20(9):1468-1474. doi:10.1093/europace/eux282
9. Sharafuddin MJA, Gu X, Titus JL, Urness M, Cervera-Ceballos JJ,
Amplatz K. Transvenous closure of secundum atrial septal defects:
Preliminary results with a new self-expanding nitinol prosthesis in a
swine model. Circulation . 1997;95(8):2162-2168.
doi:10.1161/01.CIR.95.8.2162
10. Anderson JH, Adamson T, Migliati E, et al. Perforating the GOREĀ®
CARDIOFORM septal occluder and atrial septal defect occluder to gain
access to the left atrium. Catheter Cardiovasc Interv . 2020.
doi:10.1002/ccd.28884
11. Mitacchione G, Curnis A, Forleo GB. Transseptal catheterization of
the native septum for atrial fibrillation ablation in presence of septal
occluder device: a novel approach with real-time 3D transesophageal
echocardiographic guidance. J Interv Card Electrophysiol . 2020.
doi:10.1007/s10840-020-00703-3
12. Mohanty S, Di Biase L, Mohanty P, et al. Effect of periprocedural
amiodarone on procedure outcome in patients with longstanding persistent
atrial fibrillation undergoing extended pulmonary vein antrum isolation:
Results from a randomized study (SPECULATE). Heart Rhythm .
2015;12(3):477-483. doi:10.1016/j.hrthm.2014.11.016